ABCC1 and breast carcinoma: Tanshinone IIA can also promote sensitivity of breast cancer cells to Dox by suppressing the PTEN/AKT pathway and the expression of efflux ABC transporters including P-gp, BCRP, and MRP1 (Li K. et al., 2019).